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SUMMARY
HNF4A is a nuclear hormone receptor that binds
DNA as an obligate homodimer. While all known hu-
man heterozygous mutations are associated with the
autosomal-dominant diabetes form MODY1, one
particular mutation (p.R85W) in the DNA-binding
domain (DBD) causes additional renal Fanconi syn-
drome (FRTS). Here, we find that expression of the
conserved fly ortholog dHNF4 harboring the FRTS
mutation in Drosophila nephrocytes caused nuclear
depletion and cytosolic aggregation of a wild-type
dHNF4 reporter protein. While the nuclear depletion
led to mitochondrial defects and lipid droplet accu-
mulation, the cytosolic aggregates triggered the
expansion of the endoplasmic reticulum (ER), auto-
phagy, and eventually cell death. The latter effects
could be fully rescued by preventing nuclear export
through interfering with serine phosphorylation in
the DBD. Our data describe a genomic and a non-
genomic mechanism for FRTS in HNF4A-associated
MODY1 with important implications for the renal
proximal tubule and the regulation of other nuclear
hormone receptors.
INTRODUCTION
HNF4A (HNF4a, NR2A1) is a transcription factor that belongs
to the nuclear hormone receptor superfamily. HNF4A plays a
critical role in development, cell differentiation, and meta-
bolism, particularly in the visceral endoderm, liver, intestine,
kidney, and pancreatic b cells. The most important target
genes of HNF4A belong to glucose, lipid, and drug meta-
bolism pathways (Cattin et al., 2009; Fang et al., 2012;
Maestro et al., 2007). Like all other nuclear hormone recep-
tors, HNF4A has a ligand-binding domain and a DNA-binding
domain (LBD and DBD, respectively). Long considered an
orphan receptor, the LBD of HNF4A binds fatty acids in a
reversible fashion, as suggested by several reports (Duda
et al., 2004; Wisely et al., 2002). The highly conserved DBD
recognizes the bipartite direct repeat 1 (DR1) consensus
sequence that is present in a great variety of target genes
(Fang et al., 2012). Although HNF4A only dimerizes with itself
and not with other nuclear receptors (Jiang et al., 1995), it was
recently shown that an increase in functional diversity can be
achieved by the dimerization of different splice variants
(Ko et al., 2019). The levels of nuclear HNF4A are regulated
by protein kinase C (PKC)-dependent phosphorylation of a
serine residue at position 87 in the DNA-binding domain, lead-
ing to enhanced nuclear export and proteasomal degradation
(Sun et al., 2007).
More than 2 decades ago, mutations in theHNF4A gene were
identified as the first monogenic cause of maturity-onset dia-
betes of the young type 1 (MODY1) (Yamagata et al., 1996),
usually diagnosed before the age of 25 years in patients with
negative islet cell autoantibodies. Additional MODY genes are
HNF1A and HNF1B, which functionally interact with HNF4A,
thereby defining a transcriptional network responsible for
phenotypically indistinguishable forms of MODY (Duncan
et al., 1998). Thus far, 100 MODY1 mutations have been
described for the coding region of HNF4A (Anık et al., 2015).
All of them are dominant mutations, considered to be haploin-
sufficient (Ferrer, 2002). One specific missense mutation in
the DNA-binding domain, p.R85W, causes additional defects
in the proximal tubules of the kidney or Fanconi renotubular
syndrome (FRTS; OMIM: 616026; note that due to differences
in genome annotations, this mutation has also been called
R76W and R63W). This mutation has been reported in 15 cases
from 12 unrelated families with full penetrance of the FRTS in
the carriers (Clemente et al., 2017; Hamilton et al., 2014; Im-
proda et al., 2016; Liu et al., 2018; Numakura et al., 2015; Sta-
nescu et al., 2012; Walsh et al., 2017). In the kidney, HNF4A is
exclusively expressed in proximal tubules (Marable et al.,
2018). However, why only the R85Wmutation in HNF4A causes
FRTS remains unclear.
The proximal tubule is situated close to the glomerulus and
is required for the extensive reabsorption of water, electrolytes,
and specific organic solutes. This includes low-molecular-
weight (LMW) proteins, protein-bound lipids, amino acids,
glucose, bicarbonate, and phosphate. Uptake occurs via re-
ceptor-mediated endocytosis or transepithelial transport,
which requires an unusually high amount of energy in the
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form of ATP. In proximal tubule cells, ATP is for the most part
generated by mitochondrial b-oxidation of fatty acids (Kang
et al., 2015), which are mostly taken up from the environment
(Bobulescu, 2010). FRTS, a failure of proximal tubular function,
is therefore featured by LMW proteinuria, glucosuria, aminoac-
iduria, and phosphaturia, with some forms leading to end-stage
renal disease. The most common are genetic forms affecting
endolysosomal or mitochondrial functions (Klootwijk et al.,
2015).
In Drosophila, HNF4A is well conserved (dHNF4), and its
inactivation causes the accumulation of lipid droplets (LDs) in
various tissues due to reduced mitochondrial function (B€ulow
et al., 2018; Palanker et al., 2009). Here, we used Drosophila
nephrocytes as a model for proximal tubules to study the func-
Figure 1. dHNF4 Silencing Increases Lipid
Droplet Content and Causes Mitochondrial
Dysfunction in Drosophila Nephrocytes
(A) In Drosophila third instar larvae, garland neph-
rocytes (NPs) are tethered to the esophagus (Oe)
and proventriculus (Pv) and pericardial neph-
rocytes are tethered to the heart.
(B) Confocal section with insets showing garland
nephrocytes expressing dHNF4-GFP under the
native dHNF4 promoter, stained for GFP and DNA.
Scale bars, 10 mm, insets 5 mm.
(C) Bright-field images of garland cells expressing
a reporter for dHNF4 activation, stained for lacZ
expression with X-gal. Scale bars, 10 mm.
(D) Z-projections showing staining with BODIPY
493/503 for lipid droplets in nephrocytes ex-
pressing RNAi against GFP and dHNF4. Scale
bars,10 mm, insets 5 mm.
(E) Quantification of the cell area occupied by LDs
per cell. Values were normalized to the average
value in control nephrocytes. Scattered plot rep-
resents seven independent experiments and red
lines represent medians. Mann-Whitney t test:
****p < 0.0001.
(F) Quantification of the average LD density
measured by the number of LDs per cell volume
(two independent experiments, red lines: medians,
Mann-Whitney t test: ****p < 0.0001).
(G) Quantification of the average LD size. Values
were normalized to the average value in control
nephrocytes, and bars represent means ± SDs
(two independent experiments, Mann-Whitney
t test: ****p < 0.0001).
(H) TEM sections of GFP and dHNF4-depleted
nephrocytes. Scale bars, 1 mm.
(I) Confocal sections of GFP and dHNF4-depleted
nephrocytes stained for ATP5A and DNA. Scale
bars, 10 mm, insets 5 mm.
(J) Quantification of the ATP5A staining intensity.
Values were normalized to the average value in
control nephrocytes (four independent experi-
ments, red lines: medians, Mann-Whitney t test:
****p < 0.0001).
See also Figures S1 and S2.
tion of HNF4A and the impact of the
FRTS-associated R85Wmutation. These
cells are specialized in the reabsorption
of components from the hemolymph (Helmsta¨dter and Simons,
2017; Weavers et al., 2009). The reabsorption includes filtration
via slit diaphragms and then, similar to proximal tubular cells,
endocytic uptake via the LMW receptors cubilin and amnion-
less (Helmsta¨dter and Simons, 2017; Zhang et al., 2013a). We
found that that the expression of dHNF4 harboring the FRTS
mutation affects the catabolism of LDs in nephrocytes by inter-
fering with mitochondrial function, which could be confirmed in
a mammalian renal epithelial system (Kaminski et al., 2016).
Moreover, we showed that the FRTSmutation promotes the nu-
clear export of a wild-type reporter protein, thereby reducing
transcriptional output in a dominant-negative manner and pro-
moting the formation of cytotoxic dHNF4 aggregates in the
cytosol. The cytotoxic effects could be suppressed by
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inhibiting nuclear exit and proteasomal degradation of dHNF4.
By contrast, the expression of another known close mutation in
the DBD, R89W (that leads to MODY1 but not to FRTS; Hamil-
ton et al., 2014), did not cause any dominant-negative or cyto-
toxic effects. Our data shed light on the molecular basis for the
unique effects of the FRTS mutation, with implications for lipid
metabolism in proximal tubules and for the control of other nu-
clear hormone receptors.
RESULTS
dHNF4 Controls LD Content and Mitochondria in
Nephrocytes
Nephrocytes exist in two functionally equivalent populations,
one close to the gut (garland nephrocytes) and one close to
the heart (pericardial nephrocytes) (Figure 1A). An advantage of
the garland nephrocytes is that they can easily be dissected
Figure 2. dHNF4 Overexpression Decreases Lipid Droplet Content
(A) Z-projections with insets showing LD and DNA staining in control and dHNF4-overexpressing nephrocytes. Scale bars, 10 mm, insets 5 mm.
(B) Quantification of the cell area covered by LDs per cell. Values were normalized to the average value in control nephrocytes (five independent experiments, red
lines: medians, Mann-Whitney t test: ****p < 0.0001).
(C) Quantification of the average LD density (number of LDs per cell volume) in control and dHNF4-overexpressing nephrocytes (three independent experiments,
red lines: medians, Mann-Whitney t test: ****p < 0.0001).
(D) Quantification of the average LD size. Valueswere normalized to the average value in control nephrocytes and bars representmeans ±SDs (three independent
experiments, red lines: medians, Mann-Whitney t test: non-significant [ns]).
(E) TEM sections of an LD and an LD+ dHNF4-overexpressing nephrocyte. Scale bars, 1 mm.
(F) Confocal sections of dHNF4-overexpressing nephrocytes, stained for LD, ATP5A, and DNA. Scale bars, 10 mm, insets 5 mm.
(G) Quantification of the ATP5A staining intensity in LD and LD+ cells shown in (F). Values were normalized to the average value in control nephrocytes (five
independent experiments, red lines: medians, one-way ANOVA test: ****p < 0.0001, **p < 0.01, ns: non-significant).
See also Figures S2 and S3.
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Figure 3. dHNF4highOE Leads to Nuclear Depletion of the Wild-Type Protomer
(A) Confocal sections of nephrocytes overexpressing dHNF4, stained for LD, DNA, and HA, and insets showing nuclei. Scale bars, 10 mm, insets 5 mm.
(B and C) Confocal sections of representative nuclei stained for DNA and HA of nephrocytes overexpressing dHNF4 at 18C (B) and 29C (B and C). Scale bars,
5 mm.
(D) Z-projections of nephrocytes expressing dHNF4-GFP under the native dHNF4 promoter together with control RNAi or dHNF4-HA, at 25C and 29C, stained
for GFP and DNA. Scale bars, 10 mm, insets 5 mm.
(E) Quantification of the average nuclear GFP intensity in (D). Values were normalized to control nephrocytes at 25Cand 29C (three independent experiments for
each genotype, red bars: medians, one-way ANOVA test: **p < 0.01, ****p < 0.0001).
(legend continued on next page)
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and studied ex vivo. The expression and active state of dHNF4 in
the nuclei of garland nephrocytes was addressed by two
different reporter lines: the first expresses GFP-tagged dHNF4
under its native promoter and was shown to rescue the lethality
of a dHNF4 null mutant (Palu and Thummel, 2016); the second
reporter line expresses a chimeric protein obtained by the fusion
of the DBD of GAL4 and the LBD of dHNF4, which, when acti-
vated, drives the expression of a lacZ gene (Palanker et al.,
2009). While dHNF4-GFP was readily expressed in the nuclei
of garland nephrocytes and surrounding gut tissue (Figure 1B),
the lacZ reporter was active only in nephrocytes, suggesting
an important function of dHNF4 in these cells (Figure 1C).
To better understand the function of dHNF4 in nephrocytes,
we studied LDs that were previously shown to accumulate in
several tissues of starved dHNF4 null mutants due to a reduction
in mitochondrial b-oxidation (Palanker et al., 2009). LDs can be
visualized by the lipophilic BODIPY dye that partitions into the tri-
glyceride (triacylglycerol [TAG])- and cholesterylester-filled core
of these cytoplasmic organelles. Transgenes were expressed
with the UAS-GAL4 system (Brand and Perrimon, 1993) using
Dorothy-GAL4 (Dot-GAL4) and Sns-GAL4, both of which have
previously been shown to drive expression in both nephrocyte
populations (Lovric et al., 2017; Zhang et al., 2013a, 2013b;
Zhuang et al., 2009). We used two different control RNAi trans-
genes targeting GFP or the testis-specific Pkd2 (Ko¨ttgen et al.,
2011). Compared to these control cells, depletion of dHNF4
by two different RNAi lines (dHNF4 knockdown [KD]) led to
an increase in LD content, number, and size in all garland
nephrocytes (Figures 1D–1G and S1A–S1E), which could
also be observed using transmission electron microscopy
(TEM; Figure 1H). The mitochondria of dHNF4-depleted cells
showed reduced amounts of ATP5A, which is a subunit of the
mitochondrial ATP synthase in the respiratory chain (Figures 1I,
1J, S1F, and S1G). Moreover, the accumulation of LDs in
dHNF4 KD cells could be suppressed by silencing mdy (Figures
S2A and S2B), the ortholog of the endoplasmic reticulum
(ER)-localized diacylglycerolacyltransferase 1 (DGAT1). In line
with previous studies, these findings suggest that LD accumula-
tion in nephrocytes is a result of reduced b-oxidation and subse-
quent DGAT1-dependent esterification of unmetabolized fatty
acids into TAGs (Chitraju et al., 2017; Nguyen et al., 2017;
Palanker et al., 2009).
Overexpression of dHNF4Regulates LD in anExpression
Level-Dependent Manner
In contrast to the KD, the overexpression of dHNF4 (dHNF4OE)
significantly decreased LD content in most nephrocytes (Figures
2A and 2B, inset 2), indicating an increased use of storage lipids
for mitochondrial b-oxidation. Some cells, however, exhibited
the opposite phenotypewith strong LD accumulations, as shown
in inset 1 and by the outliers in the graph of Figure 2B. LD+ cells
showed an increase in the area covered by LDs that was, unlike
dHNF4 KD, not due to an increase in size but to an augmented
LD number per cell volume (Figures 2C–2E). An enhanced
ATP5A staining was observed in LD cells, but not in LD+cells
(Figures 2F and 2G), supporting the functional correlation be-
tween LD content and mitochondrial respiratory chain activity.
To test whether the different LD phenotypes were dependent
on the expression level of dHNF4, we made use of the tempera-
ture dependency of the UAS-GAL4 system (Figure S3A) (Duffy,
2002). While low overexpression at 18C showed complete LD
depletion (Figures S3B–S3D), switching the temperature to
29C at L3 larval stages led to strong lipid accumulation (Figures
S3B–S3D) and low ATP5A levels in nephrocytes (Figure S3E).
Hereafter, the three different expression levels are referred to
as dHNF4lowOE (18C), dHNF4OE (25C), and dHNF4highOE
(29C). While the temperature itself also increased LDs to
some extent (Figure S3D), dHNF4highOE cells always had more
LDs than the controls and dHNF4lowOE always had fewer LDs
(Figures S3B–S3D). Moreover, co-expressing mdy RNAi with
dHNF4 completely abolished LDs in both dHNF4OE and
dHNF4highOE cells (Figures S2A and S2B), suggesting that similar
to dHNF4 KD, the increased LD amount, as in the KD, may be the
result of unmetabolized fatty acids being diverted toward ester-
ification and storage.
dHNF4OE Leads to Nuclear Depletion of the Wild-Type
Protomer
To better understand the phenotypic similarity between dHNF4
RNAi and dHNF4OE, we studied the localization of the overex-
pressed dHNF4 in nephrocytes, making use of its hemagglutinin
(HA) tag. We identified a spectrum of localization patterns that
matched the LD phenotypes seen in each overexpression condi-
tion: normal nuclear localization was only found in all dHNF4lowOE
and LD dHNF4OE cells (Figures 3A and 3B), whereas enrich-
ment at the lamin D+ nuclear periphery was detected for LD+
dHNF4OE cells (Figure 3A) and dHNF4highOE cells (Figures 3B
and S3F). As HNF4A normally forms dimer, we also tested ef-
fects on the dHNF4-GFP reporter protein. We found that
dHNF4OE and dHNF4highOE caused amild and a strong reduction
in nuclear dHNF4-GFP, respectively (Figures 3D and 3E). These
data suggest that the phenotypic similarity between KD and
dHNF4 overexpression may be explained by the loss of nuclear
activity of the protomer expressed from the wild-type allele.
dHNF4OE Causes Cytotoxic Effects
In dHNF4highOE cells, the nuclear depletion of dHNF4 also corre-
lated with the formation of cytoplasmic punctae that were
positive for ubiquitin (Figures 3C and S3G). As ubiquitinated ag-
gregates normally stimulate autophagy, we looked at autophagic
flux by using the GFP-mCherry-Atg8 tandem reporter (Atg8 cor-
responds to LC3 inmammals) (Kimura et al., 2007). We observed
an increase in Atg8-GFP-mCherry signal in dHNF4OE (Figure S4A
and insets). However, unlike the silencing of ATP6AP2, a subunit
of the proton pump V-ATPase, this signal did not co-localize with
GFP, suggesting that autophagic flux was enhanced (Figure S4A
(F) TEM sections of dHNF4-overexpressing nephrocytes. Arrows point to autophagic structures. Black arrowheads point to electron-dense
aggregates. White arrowheads point to multi-layering of autophagosomal membranes. Scale bars, 1 mm (first and second panels) and 500 nm (third and
fourth panels).
See also Figures S3 and S4.
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Figure 4. Blocking Degradation Signaling Prevents dHNF4-Induced Phenotypes
(A) Region of the DNA-binding domain between the two zinc fingers containing the S87 in humans, corresponding to S169 in flies.
(B) Confocal sections of representative nuclei stained for DNA and HA of nephrocytes overexpressing dHNF4S169A at 25C and 29C. Scale bars, 5 mm.
(C) Z-projections of nephrocytes expressing dHNF4-GFP under the native HNF4 promoter and dHNF4S169A at 25C and 29C, stained for GFP, HA, and DNA.
Scale bars, 10 mm, insets 5 mm.
(D) Quantification of the average nuclear GFP intensity in (C), compared to that of control and dHNF4-overexpressing nephrocytes shown in Figure 3E. Values
were normalized to control nephrocytes (three for 25C and two for 29C independent experiments, red lines: medians, one-way ANOVA test: ***p < 0.001, ****p <
0.0001, ns: non-significant).
(E) Z-projections showing control and dHNF4S169A-overexpressing nephrocytes stained for LDs and DNA. Scale bars, 10 mm.
(legend continued on next page)
4412 Cell Reports 29, 4407–4421, December 24, 2019
and insets). By performing TEM on dHNF4OE cells, we found
abundant cytoplasmic phagophores and autophagosomes,
whose limiting membranes were often multilamellar in structure
(Figure 3F). Numerous electron-dense structures could be de-
tected inside and outside the autophagosomes, possibly repre-
senting ribosomes or the aggregates themselves (Figure 3F).
Furthermore, we found in control cells a perinuclear compact
ER decorated with ribosomes, while ER structures were difficult
to detect in dHNF4OE cells (Figure 3F). This was confirmed by im-
munostaining for the luminal ER marker protein di-sulfide isom-
erase (PDI) displaying an abnormal ER expansion for LD+
dHNF4OE and dHNF4highOE (Figures S4B and S4D), while the
ER showed a normal perinuclear morphology in control cells
and in dHNF4 KD and dHNF4lowOE cells (Figures S4B and S4C).
The increase in autophagy and the ER abnormalities correlated
well with the effects on the viability of nephrocytes and of the
entire animal. With sns-GAL4, nephrocyte cytotoxicity became
apparent already at L3 larval stage, causing a reduction in cell
size and number in dHNF4OE as compared to control (Figure S4E).
With Dot-GAL4 but not Sns-GAL4, there was also a reduced ani-
mal viability, suggesting that this driver also expresses in cells be-
sides nephrocytes that are essential for survival.While animals ex-
pressing dHNF4 at 29C were dying already at L3 larval stages,
there was an intermediate phenotype at 25C with animals that
were able to survive into adulthood, albeit with a loss of nephro-
cytes (Figure S4F). By contrast, the viability of nephrocytes and
whole animals was unaffected in dHNF4KD- and dHNF4lowOE-ex-
pressing animals (data not shown).
The data suggest the following scenario: the higher the
expression of dHNF4, the more nuclear export and formation
of cytosolic aggregates, which in turn lead to ER damage, auto-
phagy, and eventually cell death. As none of these cytotoxic ef-
fects were found for dHNF4 KD, we conclude that they are
related to the cytosolic aggregates of dHNF4highOE.
Blocking Degradation Signaling Prevents dHNF4highOE-
Induced Phenotypes
The nuclear export and turnover of HNF4A was previously shown
to depend on PKC-dependent phosphorylation at the highly
conserved serine 87 (S87) in the DBD (Figure 4A) (Sun et al.,
2007). We therefore reasoned that suppressing the phosphoryla-
tionmay also suppress the loss of nuclear HNF4 and cytotoxic ef-
fects. To address this, we attempted to suppress phosphorylation
by introducing a serine-to-alanine conversion at the correspond-
ing 169 position in the fly sequence (dHNF4S169A; Figure 4A). To
avoid any confounding positional effects, the UAS transgene
was inserted at the same genomic position as the wild-type trans-
gene.We first addressed the localization of this supposedly phos-
pho-deficient form. dHNF4S169A was nuclear at both 25C and
29C (Figure 4B), as was the dHNF4-GFP reporter (Figures 4C
and 4D). Moreover, LD content was equally depleted as in
dHNF4lowOE cells (Figures 4E and 4F), and mitochondrial ATP5A
was increased in dHNF4S169A nephrocytes (Figures 4G and 4H),
suggesting that dHNF4S169A strongly promotes lipid catabolism.
In addition, autophagy, ER morphology, and viability of nephro-
cytes were normal (Figures S6A–S6C). These data suggest that
increasing nuclear dHNF4 levels by preventing nuclear export
positively regulates lipid catabolism and mitochondrial function
while suppressing any dominant-negative effects.
Renal Fanconi Syndrome-Associated Drosophila
Mutation R167W Causes LD Accumulation and
Mitochondrial Defects
Next, we investigated the impact of the MODY1 mutation R85W,
which is uniquely associated with FRTS in humans. We
compared its phenotypes to a nearby arginine-to-tryptophan
substitution, R89W, that causes MODY1 without FRTS (Fig-
ure 5A) (Hamilton et al., 2014). Previously, the crystal structure
of human HNF4A had shown that both R85 and R89 are in close
proximity to DNA and that replacing either of the arginines with
tryptophan could impair DNA binding (Bogan et al., 2000). We
confirmed this hypothesis by performing an electrophoretic
mobility shift assay (EMSA) in COS-7 cells, showing that while
HNF4 wild-type (WT) and S87A readily bound to a DNA probe
with HNF4A target motif (Jiang et al., 1995), the binding of
HNF4 R85W and R89W was strongly reduced (Figure 5B).
In flies, the arginines in positions 85 and 89 correspond to the
arginines in positions 167 and 171 (Figure 5A). We generated two
UAS transgenes harboring the twomutations, respectively (here-
after called dHNF4R167W/FRTS and dHNF4R171W/MODY). Nephro-
cytes expressing dHNF4R167W/FRTS displayed either an enrich-
ment of the HA staining at the nuclear periphery or a very weak
staining in the nucleus (Figure 5C). Nuclear localization of
dHNF4-GFP was completely lost, accompanied by a very strong
increase in GFP+ puncta in the cytosol (Figures 5D and 5E).
Accordingly, these cells displayed a strong increase in LDs (Fig-
ures 6A and 6B), which could be fully suppressed by mdy KD
(Figures S6A and S6B). In addition, mitochondrial ATP5A stain-
ing was strongly decreased (Figures 6C and 6D), while auto-
phagy was increased and ER morphology strongly disturbed
(Figures 6E and S6G). When using the Sns-GAL4 driver nephro-
cyte, loss was already apparent at early larval stages (Figure 6F).
When using the dot-GAL4 driver, there was also a strongly
reduced animal lethality. In contrast to wild-type dHNF4, these
phenotypes could even be observed at 18C (Figures S6D and
S6F), indicating that the dominant-negative effects of
dHNF4R167W/FRTS are more severe than they are for dHNF4OE.
The expression of dHNF4R171W/MODY caused no dominant-
negative effects. Instead, the situation was highly similar to the
expression of the phosphorylation-deficient dHNF4S169A: there
(F) Quantification of the cell area occupied by lipid droplets per cell in the genotypes shown in (E) compared to the cell area of nephrocytes expressing dHNF4
shown in Figure 2B. Values were normalized to control nephrocytes (three independent experiments, red lines: medians, one-way ANOVA test, ****p < 0.0001.
(G) Confocal sections of control and dHNF4S169A-overexpressing nephrocytes, stained for ATP5A and DNA. Scale bars, 10 mm, insets 5 mm.
(H) Quantification of the ATP5A staining intensity shown in (G) compared to the staining intensity of nephrocytes expressing dHNF4 (LD) shown in Figure 2G.
Values were normalized to the average value in control nephrocytes (three for dHNF4S169A and five for dHNF4OE independent experiments, red lines: medians,
one-way ANOVA test: ****p < 0.0001, **p < 0.01).
See also Figure S5.
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Figure 5. Renal Fanconi Syndrome-Associated Mutation dHNF4 (p.R167W) Causes Nuclear Depletion of the Wild-Type Protomer That Can
Be Rescued by Blocking Degradation Signaling
(A) Region of the DNA-binding domain between the two zinc fingers containing the human R85W mutation causing both MODY1 and Fanconi renotubular
syndrome (FRTS) and the R89W mutation causing MODY1, corresponding to R167W and R171W, respectively, in flies. Below is the dHNF4 double mutant
containing R167W/FRTS and S169A mutations (dHNF4R167W/S169A-HA).
(B) EMSA of COS-7 nuclear extracts containing overexpressed HNF4A WT and mutants with the ApoAI site A probe.
(legend continued on next page)
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was a normal nuclear distribution of both the transgene and
dHNF4-GFP (Figures 5C–5E). Mitochondria staining, ER
morphology, and viability were normal (Figures 6C–6F).
Similar observations were made at 29C (Figures S6C and
S6E). The only difference from dHNF4S169A was that for
dHNF4R171W/MODY, the LD content was only reduced and not
fully eliminated (Figure 6A), which is in line with the reduced
DNA binding in the EMSA assay (Figure 5B).
S169A Partially Rescues R167W/FRTS Phenotypes
To prevent phosphorylation in both mutants, we created double
mutants of S87A andR167/FRTS andR171W/MODY (Figure 5A).
As expected, the nuclear localization of R171W/MODY was un-
affected by the additional mutation (not shown). However, the
expression of R167W/S169A double mutant showed a strong in-
crease in nuclear levels compared to R167W alone (Figure 5C).
The nuclear localization of dHNF4-GFP reporter (Figures 5D
and 5E), the ER morphology (Figure 6E), and the autophagy
levels (Figure S6G) were entirely restored, suggesting sup-
pressed dominant-negative effects. Moreover, S169A caused
a striking restoration of the viability of the whole animal when us-
ing Dot-GAL4 (data not shown) and of nephrocytes when using
Sns-GAL4 as drivers (Figure 6F). Although mitochondrial
ATP5A levels seemed normalized (Figures 6C and 6D), LD con-
tent remained high in the R167W/S169A double mutant (Figures
6A and 6B), suggesting that the dephosphorylation cannot
rescue the decreased transcriptional activity. This was sup-
ported by the finding that the R85W/S87A double mutant
showed almost no detectable DNA binding in the EMSA shift
assay (Figure 5B). Therefore, our data demonstrate that prevent-
ing the mutant protein from being phosphorylated at S169 and
expelled from the nucleus for degradation strongly diminishes
all dominant-negative effects of dHNF4 without rescuing lipid
metabolism defects (Table S1).
R85W/FRTS Mutation Causes Mitochondrial
Dysfunction in Mouse Reprogrammed Renal
Epithelial-like Cells
Finally, to validate the effects of the FRTSmutation in a mamma-
lian model, we chose a direct reprogramming approach, called
induced renal epithelial cells (iRECs) (Kaminski et al., 2016), in
which HNF4A is one of three transcription factors inducing renal
epithelial cell fate (Figure 7A). In this system, HNF4A is particu-
larly important for the expression of several proximal tubular
markers (Kaminski et al., 2016), which is in agreement with in vivo
mouse studies (Marable et al., 2018). Embryonic fibroblasts were
isolated from mouse embryonic fibroblasts (MEFs) harboring
Cre-recombinase under the control of the renal tubule-specific
cadherin-16 promoter (Cdh16/Ksp-Cre) and the tandem dimer
Tomato red/EGFP (tdTomato/EGFP) dual fluorescent reporter
(Shao et al., 2002). Upon lentiviral transduction with Pax8,
Hnf1b, and HNF4A (wild-type or R85W/FRTS), cells that had
switched from Tomato to EGFP expression and thus had ac-
quired renal cell fate were isolated by fluorescence-activated
cell sorting (FACS) and then functionally characterized
(Figure 7A).
Reprogramming to iRECs was achieved with both the wild-
type HNF4A and the R85W/FRTS mutation at similar rates
(0.66% and 0.69%, respectively). We detected lower mRNA
levels of HNF4A R85W expression compared to wild-type (Fig-
ure 7B). Using immunostaining, we also found lower nuclear
staining for HNF4A R85W/FRTS protein (Figures 7C and 7D).
However, the overall changes to the transcriptional profile
analyzed by RNA sequencing (RNA-seq) were remarkably similar
between iRECs reprogrammed using wild-type HNF4A and
HNF4A R85W/FRTS, suggesting that the R85W/FRTS mutation
retains reprogramming activity and elicits overall similar changes
to the gene expression profile from fibroblasts to iRECs (Fig-
ure 7E). Cluster mapping and Gene Ontology (GO)-term enrich-
ment analysis revealed that genes related to mitochondrial
function were induced by reprogramming using wild-type
HNF4A, but they had a significantly reduced expression in cells
reprogrammed using HNF4A R85W/FRTS (Figures 7F, 7G,
S7A, and S7B).
For functional validation, we analyzed the cells with Seahorse
XF96 mitochondrial flux analyzer. iRECs reprogrammed with
R85W/FRTS showed decreased ATP production and basal
respiration together with a strongly impaired maximal respiration
(Figure 7H). Although R85W/FRTS iRECs were able to use fatty
acids for basal respiration, the treatment of the cells with the
mitochondrial fatty acid uptake inhibitor etomoxir showed that
the oxygen consumption rate via the oxidation of fatty acids
was relatively lower compared to iREC WT cells (Figure 7I).
Accordingly, due to the change in mitochondrial function, LDs
were increased in iREC R85W compared to iRECs WT (Figures
7J and 7K), confirming the nephrocyte findings in these proximal
tubule-like cells.
DISCUSSION
HNF4A is specifically expressed in the kidney in proximal tubules
and is required for the terminal differentiation of proximal tubular
cells (Jiang et al., 2003; Marable et al., 2018). However, out of all
of the known mutations, only the R85W mutation causes FRTS
(Hamilton et al., 2014). Using fly nephrocytes as a model for
proximal tubules, we show here that both dHNF4 KD and over-
expression of the FRTS mutation (R167W in flies) causes mito-
chondrial alterations and LD accumulation. By using a dHNF4-
GFP as a reporter protein, we show that the FRTS mutation pro-
vokes the nuclear export of the wild-type protomer in a
(C) Confocal sections of representative nuclei stained for DNA and HA of nephrocytes overexpressing dHNF4R167W/FRTS-HA, dHNF4R171W/MODY-HA, and
dHNF4R167W/S169A-HA. Scale bars, 5 mm.
(D) Z-projections of nephrocytes expressing dHNF4-GFP under the native dHNF4 promoter together with dHNF4R167W/FRTS-HA, dHNF4R171W/MODY-HA, and
dHNF4R167W/S169A-HA, stained for GFP and DNA. Scale bars, 10 mm, insets 5 mm.
(E) Quantification of the average nuclear GFP intensity in (A). Values were normalized to control nephrocytes (four independent experiments for dHNF4R167W/FRTS-
HA and dHNF4R171W/MODY-, three for dHNF4R167W/S169A-HA, red bars: medians, one-way ANOVA test: ****p < 0,0001, ns: non-significant).
See also Figure S6.
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Figure 6. dHNF4R167W/FRTS Causes LD Accumulation, Mitochondrial Defects, and Cytotoxic Effects That Can Be Rescued by Blocking
Degradation Signaling
(A) Z-projections showing LD andDNA staining in control, dHNF4R167W/FRTS-, dHNF4R171W/MODY-, or dHNF4R167W/S169A-overexpressing nephrocytes. Scale bars,
10 mm.
(B) Quantification of the cell area occupied by LDs per cell in the genotypes shown in (A) (five independent experiments for dHNF4R167W/FRTS, three for
dHNF4R171W/MODY and dHNF4R167W/S169A, red lines: medians, one-way ANOVA test: ***p < 0.001, ****p < 0.0001, ns: non-significant).
(legend continued on next page)
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dominant-negative manner, possibly explaining the similarity to
the KD. The nuclear export is additionally associated with cyto-
plasmic aggregate formation, increased autophagy, severe ER
morphology changes, and eventually cell death. All of these phe-
notypes are not seen in the KD, suggesting that they are the
result of the aggregate formation. However, they could be
observed when expressing wild-type dHNF4 at high levels, sug-
gesting dominant-negative effects in this condition as well. For
both dHNF4R167W/FRTS and dHNF4highOE, these effects could
be rescued by the increase in nuclear levels through dephos-
phorylation at S169.
Crucial for the understanding of the investigatedmutations are
structural studies of the HNF4A homodimer/DNA complex, in
which the homodimer forms multiple domain-domain junctions
and a convergence zone or ‘‘nerve center,’’ in which the two
LBDs, the upstream positioned DBD, and the hinge region
meet. S87 maps precisely to this center, leading to unfavorable
charge repulsion upon phosphorylation and disengagement of
the quaternary structure needed for DNA binding (Chandra
et al., 2013). In another nuclear receptor, constitutive androstane
receptor (CAR), the corresponding phosphorylation leads to the
formation of inactive homodimers (Shizu et al., 2017), providing
support for this model. As R85 is in close contact with the DNA
bases and backbone of the dipartite DR1 element in both up-
stream and downstream protomers of the homodimer (Chandra
et al., 2013), the lack of DNA binding in the R85W mutant may
promote phosphorylation-dependent conversion of active to
inactive homodimers and, finally, nuclear export of both mutant
and wild-type protomers.
By contrast, the effects of the MODY mutation R171W resem-
bled those of the phosphorylation-deficient S169A mutant,
which is supported by two phosphorylation prediction algo-
rithms (https://scansite4.mit.edu/4.0/#home and http://www.
cbs.dtu.dk/services/NetPhos/), showing that R171W/MODY (or
R89W/MODY) but not R167W/FRTS (or R85W/FRTS) reduces
the probability for phosphorylation at S169 (or S87). In addition,
the available HNF4A structure shows that R89 is closer to the
S87 convergence zone compared to R85 (Chandra et al.,
2013), which may explain that at the R171 (or R89) position,
the substitution with the bulky tryptophan could interfere with
the S169 (or the mammalian S87) phosphorylation site. Unlike
for R167W (or R85W), the reduced DNA binding of R171W (or
R89W) may therefore not result in phosphorylation-dependent
dominant-negative effects, which is consistent with the haploin-
sufficiency that has been proposed for most MODY1 mutations
(Ferrer, 2002). The reverse conclusion would be that haploinsuf-
ficiency alone is not enough to cause FRTS and that dominant-
negative effects are required in addition.
As a consequence of the nuclear export due to the dominant-
negative mechanism, we uncovered cytotoxic effects that were
not seen in the dHNF4 KD and hence are most likely linked
with the aggregation of potentially misfolded proteins in the cyto-
plasm. Our co-labeling with the nuclear envelopemarker lamin D
shows that the aggregate formation already commences during
nuclear export. It can therefore be assumed that the small nu-
clear pore size causes an accumulation of dHNF4 beneath the
nuclear envelope, which in turn favors aggregate formation.
Although the order of cytosolic events is not entirely clear, we
speculate that the aggregates first pose a challenge for the clear-
ance capacity of the proteasome, which is the normal site of
HNF4A degradation (Sun et al., 2007). As a result, the ER may
help by translocating chaperones into the cytoplasm to stimulate
autophagy, as has been described for BiP and PDI (Cha-Molstad
et al., 2015). Consequently, the ability of the ER to address its
own misfolded membrane-bound or luminal proteins could be
weakened, thereby causing ER stress. Previously, cytoplasmic
aggregates due to dominant-negative mutations or polyQ ex-
pansions have been observed in two other nuclear receptors,
the thyroid receptor and the androgen receptor, respectively
(Bunn et al., 2001). In the latter case, the cytoplasmic aggregates
were also associated with ER stress (Thomas et al., 2005).
While dHNF4 has been shown to act as a regulator of mito-
chondria gene expression in the fly (Barry and Thummel, 2016;
B€ulow et al., 2018; Palanker et al., 2009), the role of mammalian
HNF4A in regulating mitochondrial function has so far been
poorly investigated. Using the iREC system, we show here that
the R85Wmutation affects mitochondria by decreasing the tran-
scription of genes for mitochondrial structure and function. This
was accompanied by a reduction in b-oxidation, leading to LD
accumulation. As the HNF4A R85W also showed lower mRNA
levels, we were unable to assess the contribution of any domi-
nant-negative effects in this model. Also, we could not directly
measure any effects of HNF4A R85W on DNA binding as we
did in the COS-7 cell system. Nevertheless, both the nephrocyte
and iREC results suggest that the effect on mitochondria could
be one of the reasons why HNF4A R85W affects the fatty acid-
consuming proximal tubules (Kang et al., 2015). In this manner,
HNF4A-associated FRTS would be related to mitochondriopa-
thies with isolated Fanconi syndrome or Fanconi syndrome as
renal manifestation in more widespread disease (Klootwijk
et al., 2014; O’Toole, 2014; Reichold et al., 2018). Given that
HNF4A may be regulated by free fatty acids, it would be inter-
esting to explore how extensively HNF4A is controlled by the re-
absorption of exogenous fatty acids in proximal tubules (or
nephrocytes) andwhether fatty acid re-esterification and storage
in LDs counteracts HNF4A activation.
(C) Confocal sections showing nephrocytes expressingGFP-RNAi, dHNF4R167W/FRTS, HNF4R171W/MODY, or dHNF4R167W/S169A, stained for ATP5A andDNA. Scale
bars, 10 mm, insets 5 mm.
(D) Quantification of the ATP5A staining intensity shown in (C). Values were normalized to the average value in control nephrocytes (three independent exper-
iments, red lines: medians, one-way ANOVA test **p < 0.01, ***p < 0.001, ****p < 0.0001, ns: non-significant).
(E) Confocal sections showing PDI and DNA staining in nephrocytes expressing GFP-RNAi, dHNF4R167W/FRTS, dHNF4R171W/MODY, or dHNF4R167W/S169A. Scale
bars, 10 mm, insets: 5 mm.
(F) Z-projections of larval garland nephrocytes expressing GFP-RNAi, dHNF4R167W/FRTS, dHNF4R171W/MODY, or dHNF4R167W/S169A driven by Sns-GAL4 and
stained for DNA and for HRP-Cy3 staining nephrocyte membranes. Scale bars, 10 mm.
See also Figure S6 and Table S1.
Cell Reports 29, 4407–4421, December 24, 2019 4417
Figure 7. Direct Reprogramming of Mouse Embryonic Fibroblasts to iRECs Using HNF4A R85W
(A) Schematic representation of the reprogramming strategy. Mouse embryonic fibroblasts (MEFs) were isolated from the limbs of Ksp-Cre/dtTomato;EGFP
E13.5 pups and transduced with the indicated transcription factor cocktails.
(B) Relative mRNA expression level of exogenous HNF4A in iRECs HNF4AWT-V5 and iRECs HNF4AR85W-V5. qPCR primers encompass the V5 region and parts of
the coding sequence of transduced HNF4A. Values were normalized to the mTBP housekeeping gene (Mann-Whitney t test: **p < 0.01).
(C) Immunostainings of the V5-tag in HNF4AWT-V5 and HNF4AR85W-V5 iRECs. Scale bar, 10 mm.
(D) Quantification of the nuclear staining normalized to the average value of iRECs WT (three independent experiments, red lines: medians, Mann-Whitney t test,
****p < 0.0001).
(legend continued on next page)
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In conclusion, our findings establish HNF4A as a master regu-
lator of lipid metabolism in nephrocytes with high relevance for
proximal tubular cells. We further provide insight into the molec-
ular basis of HNF4A-associated FRTS that has remained enig-
matic since the identification of the first patient with the R85W
mutation (Hamilton et al., 2014). Our results suggest a rationale
for treatments aimed at preventing the nuclear export of
HNF4A in such patients. As serine phosphorylation in the DBD
has been shown to be conserved in many nuclear hormone re-
ceptors (Sun et al., 2007), blocking this phosphorylation as a
means to increase nuclear activity should also have more gen-
eral implications.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat monoclonal anti-HA Roche Cat# 11867423001, RRID:AB_390918
Mouse monoclonal anti-ATP5A Abcam Cat# ab14748, RRID:AB_301447
Rabbit anti-GFP Antibody platform
Institut Curie
N/A
Mouse monoclonal lamin Dm0 Developmental Studies
Hybridoma Bank
Cat# adl84.12, RRID:AB_528338
Mouse Mono- and polyubiquitinylated conjugates
monoclonal antibody (FK2)
Enzo Life Sciences Cat# BML-PW8810, RRID:AB_10541840
Mouse monoclonal anti-PDI (1D3) Enzo Life Sciences Cat# ADI-SPA-891, RRID:AB_10615355
Rabbit anti-p62/Ref(2)P gift from T.E. Rusten N/A
Mouse monoclonal anti-V5 Invitrogen Cat# R96025, RRID:AB_159313
Chemicals, Peptides, and Recombinant Proteins
Paraformaldehyde Science Services E15710
Glutaraldehyde Sigma-Aldrich G7526
Triton X-100 Roth 3051.3
mounting medium: Roti-Mount FluorCare Roth HP19.1
X-gal ThermoScientific R0404
polybrene Santa Cruz sc-134220
Mayer’s Hematoxylin Solution Sigma-Aldrich MHS16
Oil Red O solution Sigma-Aldrich O1391
BODIPY 493/503 Invitrogen D3922
Takyon No ROX SYBR 2X MasterMix blue dTTP Eurogentec UF-NSMT-B0701
Oligomycin Santa Cruz sc-203342
FCCP Santa Cruz sc-203578
(+)-Etomoxir sodium salt Santa Cruz sc-215009
Antimycin A Santa Cruz sc-202467
Rotenone Santa Cruz sc-203242
Critical Commercial Assays
QuikChange II Site-directed Mutagenesis kit Agilent Technologies 200523
QIAzol Lysis Reagent QIAGEN 79306
RNeasy Plus Universal Mini Kit QIAGEN 73404
QuantiTect Reverse Transcription Kit QIAGEN 205311
Odissey Infrared EMSA Kit Li-COR 829-07910
Deposited Data
RNA-seq data at GEO N/A #GSE139674
Experimental Models: Cell Lines
Monkey COS-7 cells From V. Cantagrel N/A
HEK293T/17 cells ATCC CRL-11268
Mouse embryonic fibroblasts (MEFs) reprogrammed
into induced renal epithelial cells (iRECs)
Primary cells N/A
Experimental Models: Organisms/Strains
D. melanogaster: Dot-Gal4 driver: w; P[mw, Dot-Gal4] From Z. Han N/A
D. melanogaster: Sns-Gal4 driver: w; P[mw, sns-GCN-Gal4] From S. Abmayr N/A
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Matias Simons (matias.
simons@institutimagine.org). All plasmids, oligonucleotides, cell lines, and fly strains generated in this study are available with no
restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Fly strains
Drosophila melanogaster stocks were raised on standard cornmeal food. Crosses were reared either at 25C or at 18C (e.g.,
dHNF4lowOE). For experiments performed at 29C (e.g., dHNF4highOE), crosseswere first kept at 25Cor 18Cuntil mid-to-late second
instar before switching to 29C for a duration of 24h. For the precise genotype used in each figure, see also Table S2.
Cell lines
COS-7 cells (gift byDr. Cantagrel) were cultured inDMEM (Dulbecco’smodified Eagle’smedium;GIBCO) supplementedwith 10% (v/v)
FBS (fetal bovine serum; GIBCO) penicillin/streptomycin and glutamine and were maintained in a humidified atmosphere of 5% CO2.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
D. melanogaster: RNAi of GFP: w[1118]; P{w[+mC] =
UAS-GFP.dsRNA.R}142
Bloomington Drosophila
Stock Center
BDSC #9330
D. melanogaster: RNAi of Pkd2: y[1] sc[*] v[1] sev[21];
P{y[+t7.7] v[+t1.8] = TRiP.HMC03263}attP2
Bloomington Drosophila
Stock Center
BDSC #51502
D. melanogaster: RNAi of Hnf4: y[1] v[1]; P{y[+t7.7]
v[+t1.8] = TRiP.JF02539}attP2
Bloomington Drosophila
Stock Center
BDSC #29375
D. melanogaster: RNAi of midway: y[1] sc[*] v[1] sev[21];
P{y[+t7.7] v[+t1.8] = TRiP.HMC06242}attP40/CyO
Bloomington Drosophila
Stock Center
BDSC #65963;
D. melanogaster: GFP- and FLAG-tagged Hnf4: w[1118];
PBac{y[+mDint2] w[+mC] = Hnf4-GFP.FLAG}VK00033
Bloomington Drosophila
Stock Center
BDSC #38649
D. melanogaster: hsp70-GAL4-dHNF4; UAS-nlacZ56 From Palanker/Thummel N/A
D. melanogaster: w; P[mw, UAS-GFP-mCherry-Atg8] From Dr. G. Juhasz N/A
D. melanogaster: RNAi of Hnf4: w1118; P{UAS-Hnf4-
RNAi-GD4362}
Vienna Drosophila
Resource Center
VDRC #12692
D. melanogaster: RNAi of ATP6AP2: w; P[mw,UAS-
dsRNA-ATP6AP2]KK107676
Vienna Drosophila
Resource Center
VDRC #105281;
D. melanogaster: P[mw, UAS-Hnf4-3xHA] FlyORF F000144
Oligonucleotides
Probe: IRD700-AAAGGTCCAAAGGGCGCCT Metabion N/A
Other oligonucleotides, see Table S3. N/A N/A
Recombinant DNA
Plasmid: pGW.UAS-HNF4-3xHA.attB FlyORF N/A
HNF4 alpha (NM_000457) Human Myc-tagged ORF Clone Origene Cat# RC217863
pWPXLd lentiviral vector Addgene Cat# 12258
plasmids psPax2 Addgene Cat# 12260
pMD2.G Addgene Cat# 12259
Software and Algorithms
ImageJ https://imagej.nih.gov/ij/
Imaris N/A https://imaris.oxinst.com
Galaxy platform Afgan et al., 2016 https://usegalaxy.org
Other
FastQC version 0.11.5 N/A http://www.bioinformatics.babraham.
ac.uk/projects/fastqc/
Trim Galore! version 0.4.3 N/A http://www.bioinformatics.babraham.
ac.uk/projects/trim_galore/
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iRECs were cultured on 0.1% gelatin-coated flasks in DMEM (Dulbecco’s modified Eagle’s medium; Lonza) supplemented with
10% (v/v) FBS (fetal bovine serum; GIBCO) penicillin/streptomycin and glutamine and were maintained in a humidified atmosphere
of 5% CO2. iRECs were generated from primary embryonic fibroblasts of male mice (MEFs; see below).
METHOD DETAILS
Generation of fly strains
The following stocks were used: dot-Gal4 and sns-Gal4 drivers, UAS-GFP-RNAi, UAS-Pkd2-RNAi, UAS-dHNF4-RNAi TRIP, UAS-
midway-RNAi, hnf4-HNF4-GFP.Flag and hsp70-GAL4-dHNF4; UAS-nlacZ56 were all obtained from Bloomington Stock Center.
UAS-dHNF4-RNAi, UAS-ATP6AP2-RNAi were obtained from VDRC and UAS-HNF4-3XHA was obtained from FlyORF. UAS-GFP-
mCherry-Atg8 was a kind gift from Dr. G. Juhasz. For more info see Key Resources Table.
UAS-dHNF4R167W-, UAS-dHNF4R167W/S169A-, UAS-dHNF4S169A- and UAS-dHNF4R171W expressing transgenic flies have been
created by site-directed mutagenesis using the QuikChange II Site-directed Mutagenesis kit (Agilent) according to the manufac-
turer’s instructions. Mutagenesis was performed on the pGW.UAS-dHNF4-3xHA.attB plasmid (kindly provided by FlyORF)
containing the WT extended gene region of HNF4 using the oligos listed in Table S3. All constructs were injected into flies with
the attP landing site at 86FB by Bestgene.
Immunohistochemistry, lipid droplet labeling and tissue imaging
Garland nephrocytes from third instar larvae were dissected in PBS, fixed for 20 min in 4% paraformaldehyde in PBS, washed three
times in PBS-T (PBS + 0.1% Triton X-100), and incubated overnight at 4C with primary antibodies diluted in PBS-T. After washing,
tissues were incubated for 2 h at room temperature with secondary antibodies (dilution 1:200) and Hoechst (0.5 mg ml1) diluted in
PBS-T. Tissues were washed twice in PBS-T followed by a wash in PBS. Tissues were mounted in mounting medium Roti-Mount
FluorCare (Roth). Primary antibodies usedwere rat anti-HA (1:500, Roche), mouse anti-ATP5A (1:100 Abcam), rabbit anti-GFP (1:500,
Antibody platform Institut Curie), mouse lamin Dm0 (5 mg/ml, DSHB), mouse anti-mono- and poly-ubiquitinylated conjugates (1:500,
Enzo Life Sciences), mouse anti-PDI (1:500, Enzo Life Sciences), rabbit anti-p62/Ref(2)P (1:5000, gift from T.E. Rusten). Secondary
antibodies used were fluorescent conjugated Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 633, and Alexa Fluor 647 (Invitrogen Mo-
lecular Probes). For LD labeling, BODIPY 493/503 (2.5 mg ml1, Molecular Probes) was incubated together with secondary
antibodies.
Stainings of pericardial nephrocytes were performed by dissecting the abdomen of 2 days-old female flies in cold PBS. After fix-
ation and washing as mentioned above, tissues were incubated for 2 h at room temperature with Hoechst and horseradish
peroxidase (HRP)-Cy3 conjugated (1:100, Jackson Immunoresearch lab) for staining of the cell surface. Tissues were washed
and mounted as above.
All images were acquired on a Leica TCS SP8 equipped with a 405-nm laser line and a white light laser with a 63x/1.4 DIC Lambda
blue Plan Apochrome objective.
X-gal staining
Vials with hsp70-GAL4-dHNF4; UAS-nlacZ56 third instar larvae were heat-shocked in a water bath at 37C for 30 minutes
and allowed to recover for 6 hours at 25C. Nephrocytes were then dissected in PBS, fixed in 1% glutaraldehyde (Sigma)
in PBS for 20 minutes, washed three times in PBS-T and incubated in a pre-warmed 0.2% X-gal solution for 30 minutes
at 37C in the dark. X-gal solution was obtained by adding 8% of X-gal diluted in N,N-dimethylformamide in a pre-warmed
X-gal dilution buffer (3mM K3Fe[CN]6, 3 mM K4Fe[CN]6, 0,9 mM MgCl2, 0,1% Tween in PBS). Then samples were washed in
PBS and mounted on glass slides in mounting medium. Pictures were taken on a Axioplan Zeiss microscope with a 63x Oil
objective (N.A. = 1.4).
Transmission electron microscopy
For transmission electron microscopy, nephrocytes from third instar larvae were fixed with 2.5% gluataraldehyde (Sigma) in
1X PHEM buffer pH7.3 overnight at 4C. Specimens were first post-fixed with tannic acid 1% in 0.1M cacodylate buffer pH7.2 for
30’, then with 1% osmium tetroxide for 1 hr in 0.1M cacodylate buffer pH7.2 at RT, before pre-embedding the specimens in 4%
agar type 9, dehydrating in a graded series of ethanol and embedding in Epon. After heat polymerization, thin sections were cut
with a Leica Ultramicrotome Ultracut UC7 sections (60 nm) and stained with uranyl acetate and lead citrate. Images were taken
with a Tecnai SPIRIT (FEI-Thermofisher Company at 120 kV accelerating voltage with a camera EAGLE 4K x 4K FEI-Thermofisher
Company).
Cloning and lentivirus production
For expression in COS-7 cells, mutagenesis was performed using the RC217863 construct (Origene) containing the myc-tagged
full-length coding region of human HNF4A2. To this end, the following mutations R85W, R89W, S87A, R85W/S87A were inserted
via site-directed mutagenesis (QuikChange II, Stratagene, Santa Clara, CA USA). The oligo pairs used to achieve this are listed in
Table S3. The full-length wild-type and mutant cDNA clones were all sequence-verified.
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For the lentiviral constructs, mouse transcription factors PAX8 and HNF1b were amplified using gene-specific primers coding se-
quences and cloned into the pWPXLd lentiviral vector (Addgene). The human transcription factor HNF4A was cloned into a pWPXLd
vector containing a V5 epitope tag. For insertion of the R85W mutation into the HNF4A coding sequence, the QuikChange Site-
Directed Mutagenesis Kit (Agilent) was applied using the primers listed in Table S3. For lentivirus production, the plasmids pWPXLd,
psPax2 and pMD2.G (Addgene) were transfected into HEK293T cells using the calcium phosphate method. After 48h, the superna-
tant was collected and viruses were precipitated with polyethylene glycol, centrifuged at 6800 rpm for 10minutes in an Avanti JXN-26
ultracentrifuge (Beckman-Coulter) and stored at 80C until transduction.
EMSA
The doublestranded oligonucleotide probe containing HNF4A-binding site (192 to 205 from apoA1 promoter from Metabion)
labeled with IRDye 700 was used for HNF4A EMSA analysis. The EMSA reaction (20 mL of final volume) contained 1 mL of IRDye
700-labeled DNA probe (50nM) and 2,5 mg of nuclear extracts from COS7 cells transfected with expression plasmids for HNF4A
WT or the mutants. The mixture was completed with 2 mL of 10x Binding Buffer, 2 mL of 25mM DTT/2.5% Tween20 and 1 mL of
Poly (dI-dC)1ug/mL from the Odissey Infrared EMSA kit (LI-COR). The mixture was incubated for 30 min at RT, fractionated on a
4% native polyacrylamide gel containing 50 mMTris, pH 7.5; 0.38 M glycine; and 2 mM EDTA, and imaged by using a Odyssey 
CLx Imaging System.
iREC generation and immunocytochemistry
MEFs were reprogrammed to iRECs as previously described (Kaminski et al., 2016). The only difference to the previous protocol is
that only EMX2 was not included as reprogramming factor to increase proximal tubular fate. In short, Ksp-Cre reporter MEFs (Ksp,
kidney specific protein, Cadherin-16) were obtained from limbs of E13.5 mouse embryos and kept in MEF medium (MEFM, contain-
ing Dulbeccos’s modified Eagle’s medium (DMEM), 2 mM L-glutamine, penicillin/streptomycin and 10% fetal bovine serum (FBS).
After confluency, cells were split 1:4 and transduced lentivirally with the mouse transcription factors PAX8, HNF1B and human tran-
scription factors HNF4A WT or HNF4A R85W. The following combinations of viruses were used for reprogramming: HNF1B + PAX8
(2TF), 2TF + HNF4AWT and 2TF + HNF4A R85W. Lentiviruses were diluted 1:100 to 1:1000 in MEFM containing 8mg mL-1 polybrene
(Santa Cruz) and transduced for 12 h on 6 consecutive days. Reprogrammed, GFP-positive cells were sorted 14 days after the last
viral transduction using a BD FACSAriaTM Fusion flow cytometer (Becton Dickinson).
For immunocytochemistry, cells were washed three times in PBS, fixed for 20 min in 4% paraformaldehyde in PBS, blocked for
10 min in PBS + 3% BSA + 0,1% Tween + 0,1% Triton and incubated overnight at 4C with primary antibodies diluted in PBS +
3%BSA + 0,1% tween + 0,1% triton. After washing, cells were incubated 2 h at room temperature with secondary antibodies (dilution
1:1000) and Hoechst (0.5 mg ml1) diluted in PBS + 3% BSA + 0,1% tween + 0,1% triton. Cells were washed three times in PBS and
mounted in Roti-Mount FluorCare (Roth). As primary antibody mouse anti-V5 (1:400, Invitrogen) was used, and as secondary anti-
body fluorescent conjugated Alexa Fluor 647 (InvitrogenMolecular Probes). For lipid droplet staining, iRECswerewashed three times
in PBS, fixed for 25 min in 4% paraformaldehyde in PBS, washed three times in PBS and incubated for 1h with Oil Red O solution
(Sigma) diluted with distilled water in a 3:2 ratio. Cells were counterstained with Mayer’s Hematoxylin Solution for 1 min and washed
three times in tap water.
Mitochondrial activity measurements
For measurements of the oxygen consumption rate (OCR) with the Seahorse XF bioanalyzer (Agilent Technologies), iRECs andMEFs
were seeded at a density of 20000 cells per well in a collagen coated XFe96 cell culture microplate (Agilent Technologies). 12 hours
post-plating cells were balanced for 1 hour in unbuffered XF assaymedia (Agilent Technologies) supplemented for OCR analysis with
2 mMGlutamine, 10 mMGlucose and 1 mM Sodium Pyruvate. For OCRmeasurements, compounds were injected during the assay
at the following final concentrations: oligomycin (ATP synthase inhibitor to measure respiration associated with cellular ATP produc-
tion; 1 mM), FCCP (uncoupling agent tomeasure themaximal respiration capacity; 1 mM), Rotenone andAntimycin A (ETC inhibitors to
measure the non-mitochondrial respiration; 1 mM). The data were normalized to protein content measured in each well using BCA
assay (Thermo Fisher Scientific) according to the manufacturer’s instructions. Seahorse parameters were calculated as followed:
last rate measurement before oligomycin injection – minimum rate measurement after oligomycin injection = ATP production; last
rate measurement before first injection – non-mitochondrial respiration rate = basal respiration; maximum rate measurement after
FCCP injection – non- mitochondrial respiration = maximal respiration. To determine the contribution of fatty acid oxidation to the
OCR, etomoxir (CPT1 inhibitor) was injected at a final concentration of 400 mM before the injection of the above-described com-
pounds. Basal respiration of cells treated with vehicle – Basal respiration of cells treated with etomoxir = basal respiration due to fatty
acid oxidation; Basal respiration – Basal respiration due to fatty acid oxidation = basal respiration independent of fatty acid oxidation.
For etomoxir experiments results were normalized by cell area measured with IncuCyte S3 Live-Cell Analysis System.
RNA sequencing and qPCR
Total RNA was extracted with QIAzol Lysis Reagent (QIAGEN) and isolated using the RNeasy Plus Universal Mini Kit (QIAGEN).
Library preparation and RNA sequencing were conducted by GATC Biotech AG on an Illumina platform with single-end 50 bp
mRNA sequencing. Sequencing data were uploaded to the Galaxy platform (Afgan et al., 2016), and usegalaxy.org server was
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used to analyze the data. Quality check was assessed with FastQC version 0.11.5 (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). Reads were trimmed with Trim Galore! version 0.4.3 (http://www.bioinformatics.babraham.ac.uk/projects/
trim_galore/) and aligned to the genome build GRCm38 using RNA STAR2 version 2.5.2b. Average read count after quality control
was 64million. Gene counts were calculatedwith featureCounts version 1.6.0 and differentially expressed genes (DEG) betweenMEF
and iREC WT and iREC R85W conditions were determined using DESeq2 version 1.18.1.
For quantitative PCR total RNA was extracted from iRECs which were re-sorted using a strict gating of GFP-positive cells. RNA
extraction was performed as described above. For reverse transcription to cDNA the QuantiTect Rev. Transcription Kit (QIAGEN)
was applied according to manufacturer’s instructions. The qPCR was performed on a Roche LightCycler 480 instrument using
10 ng of cDNA, gene-specific primers and Takyon SYBR Master Mix (Eurogentec, Takyon No Rox SYBR MasterMix dTTP
Blue, UF-NSMT-B0701). The primers used are listed in Table S3.
qPCR data were analyzed applying the comparative CT method (Schmittgen and Livak, 2008). RNA-seq raw data files have been
deposited in GEO (Gene expression omnibus).
QUANTIFICATION AND STATISTICAL ANALYSIS
Image analysis
For nephrocytes, percentage of total cell area occupied by LDs was quantified with the ‘‘Analyze Particles’’-tool of Fiji on thresholded
Z stack projections images of BODIPY 493/503. Average nuclear intensity of dHNF4-GFP staining in nephrocytes and whole ATP5A
staining intensity in nephrocytes were measured on the nuclear z-plane by the mean intensity using the ‘‘Analyze Measure’’- tool of
Fiji. LD size and density were measured with Imaris by defining the volume of the cell in 3D and then using the Spot Detector tool. For
calculating LD density, the number of LDs was normalized to the total volume of the segmented cell.
For IRECs, the average nuclear intensity of HNF4A-V5 was measured on the nuclear z-plane by the mean intensity using the
‘‘Analyze Measure’’-tool of Fiji. For LD staining, the percentage of the area occupied by LDs in iRECs was quantified using the
‘‘Analyze Particles’’-tool of Fiji on thresholded images.
Statistics
All experiments were repeated at least 3 times with consistent results. Statistical analysis was performed with 2-tailed, unpaired
Mann-Whitney’s t test for comparison of 2 groups, or one-way ANOVA followed by Tukey’s or Dunn’s multiple comparison test
for multiple comparisons after verifying normality. Statistical analyses were performed using the GraphPad Prism 6.0 program.
P less than 0.05 was considered significant (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). More details on statistics can be found
in each figure legend.
RNA-seq data analysis
Downstream analysis was performed using R version 3.5.0. A heatmap of the significant DEG (N = 10963) between all three analyzed
conditions was drawn using gplots version 3.0.1 (Figure 7E). For this, FPKM (Fragments Per Kilobase Million) values were calculated
for every gene, base 10 logarithmwas computed and z-score standardization was performed. Significant DEGwere then divided into
12 clusters using soft clustering tool Mfuzz (Kumar and Futschik, 2007). Computed clusters were assigned to eight logically expected
expression change patterns (Figure S7). We were not able to assign any genes to logically expected cluster number six representing
genes being downregulated in iREC WT and mutation conditions compared to MEFs.
A GO over-representation test was done using Bioconductor package clusterProfiler version 3.8.1 (Yu et al., 2012) and not more
than five most significant terms from each biological domain of clusters one, three, four, seven and eight were plotted (Figure 7F).
With genes representing mitochondrial gene expression GO term (GO:0140053) a heatmap was plotted as outlined above.
DATA AND CODE AVAILABILITY
RNA-seq datasets have been deposited in GEO (Gene expression omnibus) under the accession number #GSE139674.
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